Maintenance Chemotherapy with S-1 Following SOX Regimen Chemotherapy Improves Prognosis of Stage 3 Gastric Cancer After D2 Gastrectomy: A 5-Year Analysis

OBJECTIVE: To assess the effectiveness and safety of treatment consisting of maintenance chemotherapy (MCT) with S-1 following S-1 plus oxaliplatin (SOX) chemotherapy for stage 3 gastric cancer (GC) after D2 gastrectomy. METHODS: In this retrospective study, we enrolled 255 patients with stage 3 GC...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Chengwu, Feng, Wenming, Bao, Ying, Chen, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733412/
https://www.ncbi.nlm.nih.gov/pubmed/33324076
http://dx.doi.org/10.2147/OTT.S271884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733412/
https://www.ncbi.nlm.nih.gov/pubmed/33324076
http://dx.doi.org/10.2147/OTT.S271884

Ejemplares similares